Sanofi Was Mystery Bidder That Lost Reata to Biogen
Biogen Inc. narrowly beat out Sanofi SA to clinch its $7.3 billion acquisition of Reata Pharmaceuticals, according to
1970-01-01 08:00
Tainted Medication Fears Spur US Defense Department to Seek Outside Testing
The US Department of Defense entered an agreement with Valisure, an independent lab that’s spotted dangerous chemicals in
1970-01-01 08:00
A $2.8 Million Miracle Therapy Eludes Some Long-Suffering Patients
Liany Benedi long dreamed of a cure for the disease that has shadowed her since she was 2
1970-01-01 08:00
Elon Musk's Neuralink Raises $280 Million to Develop Brain Implants
Neuralink Corp., Elon Musk’s brain-implant company, has raised $280 million in new funding from investors to develop its
1970-01-01 08:00
Sage Tumbles as Depression Pill Approval Omits Major Disorder
Sage Therapeutics Inc. slumped in early trading after regulators granted approval to its fast-acting pill only for postpartum
1970-01-01 08:00
Astellas Pharma Secures US FDA Approval for Izervay
The US Food and Drug Administration approved Astellas Pharma Inc.’s Izervay for the treatment of age-related macular degeneration,
1970-01-01 08:00
AstraZeneca, Sanofi RSV Drug for Infants Wins CDC Backing
A drug from AstraZeneca Plc and Sanofi to protect infants against a potentially fatal respiratory illness won backing
1970-01-01 08:00
Could Your Sunscreen Be Contributing to Beach Erosion?
“It’s raining,” Conrad Downs, 9, told his dad, not exactly happy to have been dropped off by a
1970-01-01 08:00
China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US
As drugmakers in the US steel for price negotiations ushered in by President Joe Biden’s Inflation Reduction Act,
1970-01-01 08:00
Global Abortion Pill Provider Buys From Manufacturer With Shoddy Quality Record
With splashy marketing campaigns and major donors like the Bill & Melinda Gates Foundation, DKT International has become
1970-01-01 08:00
Biogen to Buy Reata for $7.3 Billion in Rare-Disease Expansion
Biogen Inc. agreed to acquire Reata Pharmaceuticals Inc. for $7.3 billion including debt to expand its rare disease
1970-01-01 08:00
Trump, DeSantis Clash in Iowa at Crucial Moment in 2024 Race
Donald Trump and Ron DeSantis’s Iowa appearances Friday mark one of the most climactic moments of the early
1970-01-01 08:00